95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.92%
Revenue growth at 50-75% of NEM's 34.04%. Martin Whitman would worry about competitiveness or product relevance.
42.28%
Gross profit growth at 50-75% of NEM's 68.04%. Martin Whitman would question if cost structure or brand is lagging.
51.76%
EBIT growth below 50% of NEM's 160.77%. Michael Burry would suspect deeper competitive or cost structure issues.
51.76%
Operating income growth under 50% of NEM's 160.77%. Michael Burry would be concerned about deeper cost or sales issues.
41.64%
Net income growth under 50% of NEM's 143.90%. Michael Burry would suspect the firm is falling well behind a key competitor.
37.50%
EPS growth under 50% of NEM's 141.86%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
37.50%
Diluted EPS growth under 50% of NEM's 141.86%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.11%
Share change of 0.11% while NEM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.43%
Diluted share count expanding well above NEM's 0.12%. Michael Burry would fear significant dilution to existing owners' stakes.
-55.10%
Dividend reduction while NEM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
50.27%
OCF growth under 50% of NEM's 140.36%. Michael Burry might suspect questionable revenue recognition or rising costs.
49.75%
FCF growth under 50% of NEM's 238.54%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
153.70%
Positive 10Y revenue/share CAGR while NEM is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
80.52%
5Y revenue/share CAGR above 1.5x NEM's 1.25%. David Dodd would look for consistent product or market expansions fueling outperformance.
48.97%
3Y revenue/share CAGR above 1.5x NEM's 11.98%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
148.05%
10Y OCF/share CAGR above 1.5x NEM's 14.74%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
106.30%
5Y OCF/share CAGR above 1.5x NEM's 27.95%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
73.89%
3Y OCF/share CAGR 1.25-1.5x NEM's 54.65%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
65.93%
Positive 10Y CAGR while NEM is negative. John Neff might see a substantial advantage in bottom-line trajectory.
240.67%
5Y net income/share CAGR above 1.5x NEM's 148.77%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
121.59%
3Y net income/share CAGR 50-75% of NEM's 170.34%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
115.16%
10Y equity/share CAGR above 1.5x NEM's 13.59%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
15.09%
5Y equity/share CAGR at 50-75% of NEM's 27.47%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
7.84%
Below 50% of NEM's 35.05%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
102.78%
Below 50% of NEM's 770.13%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
0.17%
Below 50% of NEM's 233.54%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
144.82%
AR growth well above NEM's 27.06%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-0.70%
Negative asset growth while NEM invests at 1.67%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.37%
75-90% of NEM's 2.83%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-23.76%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-2.17%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.